Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Capital Employed (2020 - 2026)

Biodesix filings provide 7 years of Return on Capital Employed readings, the most recent being 32.57% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 901.0% to 32.57% in Q1 2026 year-over-year; TTM through Mar 2026 was 32.57%, a 901.0% increase, with the full-year FY2025 number at 37.2%, up 394.0% from a year prior.
  • Return on Capital Employed hit 32.57% in Q1 2026 for Biodesix, up from 39.44% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 32.57% in Q1 2026 to a low of 152.13% in Q3 2022.
  • Median Return on Capital Employed over the past 5 years was 58.12% (2024), compared with a mean of 73.29%.
  • Biggest five-year swings in Return on Capital Employed: crashed -11512bps in 2022 and later skyrocketed 6155bps in 2024.
  • Biodesix's Return on Capital Employed stood at 91.62% in 2022, then grew by 24bps to 69.45% in 2023, then skyrocketed by 42bps to 40.27% in 2024, then grew by 2bps to 39.44% in 2025, then increased by 17bps to 32.57% in 2026.
  • The last three reported values for Return on Capital Employed were 32.57% (Q1 2026), 39.44% (Q4 2025), and 46.45% (Q3 2025) per Business Quant data.